SCHEMBL6849987

SCHEMBL6849987

COc1cccc(C(OCCCCCCCCCCO)(c2ccccc2)c2ccccc2)c1OC

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.40
ALDH1A1 P00352 5/20 0.39
HSD17B10 Q99714 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.38
TSHR P16473 1/20 0.38
KDM4E B2RXH2 1/20 0.37
TK2 O00142 4/20 0.36
KIF11 P52732 1/20 0.36
GAA P10253 1/20 0.34
HPGD P15428 1/20 0.34
LMNA P02545 1/20 0.34
MAPT P10636 1/20 0.34
CNR1 P21554 1/20 0.34
CNR2 P34972 1/20 0.34
NFE2L2 Q16236 1/20 0.34
MEN1 O00255 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2D6 P10635 1/20 0.34
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1260570 1.00 SMN1; SMN2 (0.40) SMN1; SMN2ALDH1A1HSD17B10L3MBTL1TSHR
SCHEMBL15841458 0.88 ALDH1A1 (0.42) SMN1; SMN2ALDH1A1HSD17B10L3MBTL1KDM4E
SCHEMBL1260567 0.88 ALDH1A1 (0.42) SMN1; SMN2ALDH1A1HSD17B10L3MBTL1KDM4E
SCHEMBL2491447 0.85 KIF11 (0.40) SMN1; SMN2ALDH1A1HSD17B10KDM4ETK2
SCHEMBL7050166 0.84 SMN1; SMN2 (0.41) SMN1; SMN2L3MBTL1TK2KIF11GAA
Lithium SCHEMBL29904177 0.82 SMN1; SMN2 (0.41) SMN1; SMN2ALDH1A1L3MBTL1KDM4EKIF11
SCHEMBL27859727 0.80 SMN1; SMN2 (0.39) SMN1; SMN2L3MBTL1KDM4EKIF11GAA
SCHEMBL2288437 0.79 ALDH1A1 (0.40) SMN1; SMN2ALDH1A1L3MBTL1TSHRKDM4E
SCHEMBL2494552 0.79 KIF11 (0.42) SMN1; SMN2ALDH1A1HSD17B10L3MBTL1TSHR
SCHEMBL20032425 0.79 KIF11 (0.55) ALDH1A1TSHRTK2KIF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6828427-B1 Oligomeric aminodiol-containing compounds, libraries thereof, and process of preparing the same ISIS PHARMACEUTICALS, INC. 2004-12-07 US disclosed
EP-0751948-B1 NOVEL PHOSPHORAMIDATE AND PHOPHOROTHIOAMIDATE OLIGOMERIC COMPOUNDS ISIS PHARMACEUTICALS INC (US) 2002-09-25 EP disclosed
US-6184389-B1 FEATURE A PLURALITY OF FUNCTIONAL GROUPS ATTACHED TO BACKBONE AND PHOSPHORAMIDATE SITES ISIS PHARMACEUTICALS, INC. 2001-02-06 US disclosed
EP-0865439-A4 COMBINATORIAL LIBRARIES HAVING AMINODIOL MONOMER SUBUNITS ISIS PHARMACEUTICALS INC (US) 1998-11-11 EP disclosed
EP-0865439-A1 COMBINATORIAL LIBRARIES HAVING AMINODIOL MONOMER SUBUNITS ISIS PHARMACEUTICALS, INC. (US) 1998-09-23 EP disclosed
US-5717083-A COMPLEXING WITH PROTEINS, NUCLEIC ACIDS, LIPIDS ISIS PHARMACEUTICALS, INC. (US) 1998-02-10 US disclosed
US-5637684-A BINDING PROTEINS, NUCLEIC ACIDS, LIPIDS; PHOSPHOLIPASE INHIBITOR ISIS PHARMACEUTICALS, INC. (US) 1997-06-10 US disclosed
EP-0751948-A4 NOVEL PHOSPHORAMIDATE AND PHOPHOROTHIOAMIDATE OLIGOMERIC COMPOUNDS ISIS PHARMACEUTICALS INC (US) 1997-03-19 EP disclosed
EP-0751948-A1 NOVEL PHOSPHORAMIDATE AND PHOPHOROTHIOAMIDATE OLIGOMERIC COMPOUNDS ISIS PHARMACEUTICALS, INC. (US) 1997-01-08 EP disclosed
WO-1996040672-A1 COMBINATORIAL LIBRARIES HAVING AMINODIOL MONOMER SUBUNITS ISIS PHARMACEUTICALS, INC. (US) 1996-12-19 WO disclosed
WO-1995023160-A1 NOVEL PHOSPHORAMIDATE AND PHOPHOROTHIOAMIDATE OLIGOMERIC COMPOUNDS ISIS PHARMACEUTICALS, INC. (US) 1995-08-31 WO disclosed